Novo Nordisk Slovakia s.r.o. is the Slovak affiliate of Novo Nordisk, responsible for the distribution, marketing and regulatory support of the company's pharmaceutical portfolio. Its business segments focus on therapies for diabetes, obesity and rare endocrine and metabolic disorders, including modern insulins, antidiabetic agents and innovative treatments for chronic diseases. The company supplies hospitals, specialised centres, wholesalers and pharmacies nationwide. It is integrated into the company's European organisational structure, benefiting from global research, clinical development and medical education capabilities. Key assets include a strong therapeutic portfolio, institutional relationships within diabetology and endocrinology sectors and a long-standing global brand. Strategically, Novo Nordisk Slovakia aims to expand access to innovative chronic disease therapies, support patient education and strengthen cooperation with healthcare professionals to improve disease management outcomes.
Headquarters
ROSUM, Bajkalska, 19B
Bratislava; Bratislavsky;
Postal Code: 82101
Contact Details: Purchase the Novo Nordisk Slovakia S.R.O. report to view the information.
Website: http://www.modrykruh.sk
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service